Koichi Nakatani

Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases

Kohei Fujita, Naohiro Uchida, Osamu Kanai et al. · Cancer Chemotherapy and Pharmacology · 2018 · 92 citations

Medicine, Emerging Reports, Immune Checkpoint Inhibitor +5

Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies

Kohei Fujita, Naohiro Uchida, Yuki Yamamoto et al. · Anticancer Research · 2019 · 65 citations · Full text

Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab

Naohiro Uchida, Kohei Fujita, Koichi Nakatani et al. · Respirology Case Reports · 2017 · 47 citations · Full text

Impact of <scp>COVID</scp> ‐19 pandemic on lung cancer treatment scheduling

Kohei Fujita, Takanori Ito, Zentaro Saito et al. · Thoracic Cancer · 2020 · 44 citations · Full text

Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody

Kohei Fujita, Yuki Yamamoto, Osamu Kanai et al. · Thoracic Cancer · 2019 · 43 citations · Full text